期刊文献+

依达拉奉对帕金森病小鼠黑质多巴胺能神经元的形态学影响 被引量:1

Effects of Edaravone Administration on Morphological Changes of Dopaminergic Neurons in Substantia Nigra of Parkinson's Mice
原文传递
导出
摘要 [目的]探讨依达拉奉对帕金森病(Parkinson’s disease,PD)小鼠黑质多巴胺神经元的作用,为依达拉奉临床PD治疗提供实验依据。[方法]将30只健康雄性C57BL/6小鼠随机分为对照组、模型组和治疗组,每组10只。模型组和治疗组给予腹腔注射百草枯(paraquat)和代森锰(maneb)建立PD模型,完成建模后,治疗组给予依达拉奉治疗。观察3组小鼠行为学的改变、并用免疫组织化学和体视学方法对黑质酪氨酸羟化酶阳性神经元进行计数和形态计量分析。[结果]模型组与治疗组比较,自主运动活性明显减少,差异有统计学意义(P<0.05);与治疗组相比,模型组黑质酪氨酸羟化酶阳性神经元数量明显降低,细胞胞体肿胀,平均截面积、平均周长和平均体积明显增大,差异均有统计学意义(P<0.05或P<0.01);胞浆内染色极为浅淡,轴突减少或消失,细胞轮廓不清。[结论]依达拉奉对PD小鼠黑质多巴胺能神经元有明显的神经保护作用。 [Objective] To investigate the protective effect of edaravone on substantia nigra dopaminergic neurons in mice with Parkinson's disease(PD).[Methods] A total of 30 male C57BL/6 mice were randomly divided into control group,model group and treatment group.Model group and treatment group were intraperitoneally injected with paraquat(PQ) and maneb(Mb) to establish PD model.Treatment group were then administrated with edaravone.Their motor coordination and expression of tyrosine hydroxylase(TH) in the substantia nigra pars compacta(SNc) were detected by immunohistochemistry and stereology.[Results] Administration of edaravone significantly attenuated the impairment of behavioral performance(P 0.05),increased the number of TH-positive neurons and improved the cell morphology such as cell body,average sectional area,circumference and volume in SNc(P 0.05 or P 0.01).[Conclusion] The present findings suggest that edaravone has a beneficial influence on nigrostriatal dopaminergic neurons in PD mice.
出处 《环境与职业医学》 CAS 北大核心 2012年第4期246-248,共3页 Journal of Environmental and Occupational Medicine
基金 贵州省社会发展科技攻关计划项目(编号:黔科合SY字[2008]3046号)
关键词 帕金森病 依达拉奉 百草枯 代森锰 形态学 体视学 Parkinson's disease edaravone paraquat maneb morphology stereology
  • 相关文献

参考文献18

  • 1PAN-MONTOJO F,ANICHTCHIK O,DENING Y. Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice[J].PLoS One,2010,(01):e8762.doi:10.1371/journal.pone.0008762.
  • 2D E RIJK M C,LAUNER L J,BERGER K. Prevalence of Parkinson's disease in Europe:A collaborative study of populationbased cohorts.Neurologic Diseases in the Elderly Research Group[J].Neurology,2000,(1 1):S21-S23.
  • 3HU X,ZHANG D,PANG H. Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease[J].Journal of Immunology,2008,(10):7194-7204.
  • 4KAWAI H,NAKAI H,SUGA M. Effects of a novel free radical scavenger,MCI-186,on ischemic brain damage in the rat distal middle cerebral artery occlusion model[J].Journal of Pharmacology and Experimental Therapeutics,1997,(02):921-927.
  • 5SHICHINOHE H,KURODA S,YASUDA H. Neuroprotective effects of the free radical scavenger Edaravone(MCI-186)in mice permanent focal brain ischemia[J].Brain Research,2004,(02):200-206.
  • 6CHEN J X,ZHAO T,HUANG D X. Protective effects of edaravone against cobalt chloride-induced apoptosis in PC12 cells[J].Neurosci Bull,2009,(02):67-74.
  • 7BARCLAY L L,GIBSON G E. Spontaneous open-field behavior in thiamin-deficient rats[J].Journal of Nutrition,1982,(10):1899-1905.
  • 8TAYLOR TN,GREENE JG,MILLER GW. Behavioral phenotyping of mouse models of Parkinson's disease[J].Behavioural Brain Research,2010,(01):1-10.
  • 9CICCHETTI F,DROUIN-OUELLET J,GROSS RE. Environmental toxins and Parkinson's disease:what have we learned from pesticideinduced animal models[J].Trends in Pharmacological Sciences,2009,(09):475-483.
  • 10DI MONTE DA,LAVASANI M,MANNING-BOG AB. Environmental factors in Parkinson's disease[J].Neurotoxicology,2002,(4-5):487-502.

二级参考文献3

共引文献1

同被引文献7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部